3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
23
Burkitt Lymphoma
14
Sarcoma
13
Neoplasms
11
Lymphoma, Follicular
11
Lymphoma
10
Hodgkin Disease
9
Breast Neoplasms
9
Triple Negative Breast Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Endometrial Neoplasms
8
Ovarian Neoplasms
7
Lymphoma, B-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Wilms Tumor
4
Recurrence
4
Osteosarcoma
4
Neoplasm Metastasis
4
Liposarcoma
4
Fallopian Tube Neoplasms
4
Sarcoma, Ewing
3
Neuroblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Leiomyosarcoma
3
Interventions
Cyclophosphamide
4
fludarabine phosphate
3
ibrutinib
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Mesna
2
Bone Marrow Transplantation
2
pirtobrutinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
Surveys and Questionnaires
1
Patient Reported Outcome Measures
1
Melphalan
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphoid
×
Doxorubicin
×
90 days
×
Clear all
No trials found.